American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 213-216, February 2010

Why Do Patients Develop Proteinuria With Sirolimus? Do We Have the Answer?

  • Jeremy R. Chapman, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Jeremy R. Chapman, MD, Department of Renal Medicine, Westmead Hospital, Westmead, Sydney, NSW 2145 Australia
    • ,
  • Gopala K. Rangan, PhD

Westmead Hospital, Sydney, Australia

No abstract is available. To read the body of this article, please view the Full Text online.

 

PII: S0272-6386(09)01572-8

doi:10.1053/j.ajkd.2009.12.003

Refers to article:

  • Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial , 18 November 2009

    Stefan Franz, Axel Regeniter, Helmut Hopfer, Michael Mihatsch, Michael Dickenmann
    American Journal of Kidney Diseases February 2010 (Vol. 55, Issue 2, Pages 335-343)

American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 213-216, February 2010

Article Tools

* Image Usage & Resolution